Skip to main content

TNF Pharmaceuticals, Inc. (TNFA) Stock Forecast


Stock Price Forecast

July 18, 2025


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading TNF Pharmaceuticals, Inc. chart...

About the Company

We do not have any company description for TNF Pharmaceuticals, Inc. at the moment.

Exchange

Nasdaq

$0M

Total Revenue

None

Employees

$1M

Market Capitalization

-0.16

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest News on TNF Pharmaceuticals, Inc.

MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF ...

1y ago, source: Seeking Alpha

TNF Pharmaceuticals retains the registered trademark MYMD-1® for its lead drug program. The Company’s new Investors website address is ir.tnfpharma.com. About TNF Pharmaceuticals, Inc.

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting ...

12mon ago, source: Business Wire

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (formerly known as MyMD Pharmaceuticals, Inc.), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing ...

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug ...

3mon ago, source: Nasdaq

TNF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health announce the application ...

Contrasting TNF Pharmaceuticals (TNFA) and Its Competitors

3mon ago, source: ETF Daily News

TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in ...

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial ...

8mon ago, source: Business Wire

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (formerly known as MyMD Pharmaceuticals, Inc.), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing ...

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha ...

4mon ago, source: Morningstar

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the ...

TNF Pharmaceuticals and Renova Health Report Positive Results in ...

3mon ago, source: Morningstar

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the ...

TNF Pharmaceuticals Inc. Research & Ratings | TNFA | Barron's

12mon ago, source: Barron's

TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel ...

TNF Pharmaceuticals Announces Positive Clinical Data Supporting ...

7mon ago, source: Seeking Alpha

TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), a clinical stage pharmaceutical company committed to extending healthy lifespan, is focused on developing two novel therapeutic platforms that treat the ...

TNF Pharmaceuticals (TNFA) & The Competition Head to Head Review

3mon ago, source: ETF Daily News

TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in ...

TNF Pharmaceuticals Inc. (TNFA) Stock Price Today - WSJ

12mon ago, source: Wall Street Journal

View the latest TNF Pharmaceuticals Inc. (TNFA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program ... - Nasdaq

12mon ago, source: Nasdaq

TNF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, and autoimmune and inflammatory conditions, today announced ...

Similar Companies
Company Ticker 90 Days Forecast Market Cap. (USD M) P/E P/B
ACHIEVE LIFE SCIENCES, INC. ACHV Predict 126.70 -3.70 3.04
Aspira Women's Health Inc. AWH Predict 1.79 -0.51 -0.70
Aspira Women's Health Inc. AWHL Predict 9.27 None None
BIOMERICA INC BMRA Predict 5.05 -0.80 0.94
BURZYNSKI RESEARCH INSTITUTE INC BZYR Predict 4.60 None None
Cardio Diagnostics Holdings, Inc. CDIO Predict 6.32 -2.34 0.65
Cardio Diagnostics Holdings, Inc. CDIOW Predict 1.79 None 0.48
Celldex Therapeutics, Inc. CLDX Predict 1693.05 -10.12 2.58
IMMUCELL CORP /DE/ ICCC Predict 55.18 31.32 1.85
IDEXX LABORATORIES INC /DE IDXX Predict 52948.18 53.72 36.30
Insight Molecular Diagnostics Inc. IMDX Predict 81.79 None 8.00
Lantheus Holdings, Inc. LNTH Predict 3962.25 14.62 3.40
MYRIAD GENETICS INC MYGN Predict 531.60 -8.61 1.37
NEOGEN CORP NEOG Predict 1211.07 -145.74 0.46
Intellia Therapeutics, Inc. NTLA Predict 1225.39 -2.58 1.57
Insight Molecular Diagnostics Inc. OCX Predict 80.94 -0.69 7.92
QuidelOrtho Corp QDEL Predict 1773.06 -1.62 0.64
Alpha Teknova, Inc. TKNO Predict 250.98 -8.59 3.30
TNF Pharmaceuticals, Inc. TNFA Predict 1.25 -0.16 0.14
VOLITIONRX LTD VNRX Predict 74.64 2.71 -2.52

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...